We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ALVR market cap is 92.39M. The company's latest EPS is USD -1.6694 and P/E is -0.49.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -42.95M | -40.43M | -43.23M | -47.3M | -46.96M |
| Net Income | -42.07M | -38.14M | -41.18M | -45.27M | -44.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 165k | 0 | 0 | 0 | 0 |
| Operating Income | -26.7M | -71.31M | -172.27M | -171.2M | -181.33M |
| Net Income | -23.84M | -69.78M | -171.96M | -168.71M | -190.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 293.7M | 277.08M | 244.04M | 282.69M | 248.31M |
| Total Liabilities | 40.47M | 52.56M | 50.51M | 53.58M | 52.98M |
| Total Equity | 253.23M | 224.52M | 193.53M | 229.11M | 195.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 139.42M | 370.82M | 286.59M | 277.08M | 190.8M |
| Total Liabilities | 17.8M | 17.76M | 61.33M | 52.56M | 45.02M |
| Total Equity | -51.5M | 353.06M | 225.27M | 224.52M | 145.78M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -110.48M | -142.05M | -32.12M | -59.24M | -93.72M |
| Investing | -94.02M | -80.48M | 41.72M | 79.62M | 12.77M |
| Financing | 126.67M | 126.96M | N/A | 70.48M | 70.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.16M | -60.81M | -106.32M | -142.05M | -124.45M |
| Investing | -64.64M | -169.5M | 185.98M | -80.48M | 37.99M |
| Financing | 120.92M | 291.98M | 232k | 126.96M | 70.5M |
| Market Cap | 92.39M |
| Price to Earnings Ratio | -0.49 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.03 |
| Price to Book Ratio | 0.63 |
| Dividend Yield | - |
| Shares Outstanding | 114.06M |
| Average Volume (1 week) | 253.17k |
| Average Volume (1 Month) | 356.36k |
| 52 Week Change | -76.72% |
| 52 Week High | 6.12 |
| 52 Week Low | 0.6231 |
| Spread (Intraday) | 0.04 (4.7%) |
| Company Name | AlloVir Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.allovir.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
